Daily FNArena News - Australia

Citi has initiated coverage on QRxPharma, seeing significant upside potential as the company develops its products designed for the moderate-to-severe pain relief market.

RBS looks at the US reporting season now underway while GSJB Were assesses earnings risk to local companies, plus more.

Morgan Stanley has initiated on 10 emerging companies with nine positive ratings, while both JP Morgan and Credit Suisse have also identified value elsewhere in the sector.

Macquarie notes a sharp drop off in sales of electronic goods while Merrill Lynch downgrades all food retailers.

Deutsche becomes the latest broker to query bank earnings forecasts while RBS evaluates NAB’s latest UK moves.

NAB’s Monthly Business Survey for March showed a strong lift in business conditions and still strong confidence levels, causing the bank to lift its growth forecasts for the Oz economy.

The RBA may have to change the way it approaches interest rates given the dominance of the booming resource states over the sluggish southern states.

Economist responses to the latest data releases and anticipated monetary policy impact. Housing finance demand in Australia falls again.

RMB revaluation rumours, Greece and increased growth expectations are keeping global financial markets in a positive mood.

Australian labour force data for March met market expectations with a 19,600 rise in jobs and unemployment unchanged at 5.3%.